tiprankstipranks
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
US Market

Sonnet BioTherapeutics Holdings (SONN) Income Statement

Compare
509 Followers

Sonnet BioTherapeutics Holdings Income Statement

Last quarter (Q1 2025), Sonnet BioTherapeutics Holdings's total revenue was $1.00M, an increase of 5268.84% from the same quarter last year. In Q1, Sonnet BioTherapeutics Holdings's net income was $-3.16M. See Sonnet BioTherapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
$ 18.63K$ 147.81K$ 349.94K$ 483.63K$ 0.00
Gross Profit
$ 18.63K$ -11.67M$ 256.69K$ -16.15M$ -58.31K
Operating Expenses
$ 11.87M$ 18.94M$ 30.02M$ 25.57M$ 17.41M
Depreciation and Amortization
$ 0.00$ 75.75K$ 93.26K$ 95.16K$ 58.31K
EBITDA
$ -11.85M$ -18.72M$ -29.58M$ -24.99M$ -24.24M
Operating Income
$ -11.85M$ -18.79M$ -29.67M$ -25.09M$ -24.24M
Other Income/Expenses
$ 4.41M$ -40.08K$ -52.48K$ 103.47K$ -27.34K
Pretax Income
$ -7.44M$ -18.83M$ -29.72M$ -24.98M$ -24.27M
Net Income
$ -7.44M$ -18.83M$ -29.77M$ -25.01M$ -31.06M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -11.35$ -18.14$ -150.79$ -313.76$ -1.02K
Diluted EPS
$ -11.35$ -18.14$ -150.79$ -313.76$ -1.02K
Weighted Average Shares Outstanding
655.24K 1.04M 197.46K 79.70K 30.59K
Weighted Average Shares Outstanding (Diluted)
655.24K 1.04M 197.46K 79.70K 30.59K
Currency in USD

Sonnet BioTherapeutics Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis